277 related articles for article (PubMed ID: 33096752)
21. AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes.
Sun X; Zhang W; Gou C; Wang X; Wang X; Shao X; Chen X; Chen Z
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167211. PubMed ID: 38701957
[TBL] [Abstract][Full Text] [Related]
22. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
23. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.
Teng Y; Girvan AC; Casson LK; Pierce WM; Qian M; Thomas SD; Bates PJ
Cancer Res; 2007 Nov; 67(21):10491-500. PubMed ID: 17974993
[TBL] [Abstract][Full Text] [Related]
24. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
25. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
[TBL] [Abstract][Full Text] [Related]
26. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract][Full Text] [Related]
28. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
Shieh YA; Yang SJ; Wei MF; Shieh MJ
ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
[TBL] [Abstract][Full Text] [Related]
29. Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides.
Choi EW; Nayak LV; Bates PJ
Nucleic Acids Res; 2010 Mar; 38(5):1623-35. PubMed ID: 20008101
[TBL] [Abstract][Full Text] [Related]
30. Backbone modified TBA analogues endowed with antiproliferative activity.
Esposito V; Russo A; Amato T; Varra M; Vellecco V; Bucci M; Russo G; Virgilio A; Galeone A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1213-1221. PubMed ID: 27663232
[TBL] [Abstract][Full Text] [Related]
31. AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.
Kabirian-Dehkordi S; Chalabi-Dchar M; Mertani HC; Le Guellec D; Verrier B; Diaz JJ; Mehrgardi MA; Bouvet P
Nanomedicine; 2019 Oct; 21():102060. PubMed ID: 31336175
[TBL] [Abstract][Full Text] [Related]
32. The influencing factors and functions of DNA G-quadruplexes.
Yuan WF; Wan LY; Peng H; Zhong YM; Cai WL; Zhang YQ; Ai WB; Wu JF
Cell Biochem Funct; 2020 Jul; 38(5):524-532. PubMed ID: 32056246
[TBL] [Abstract][Full Text] [Related]
33. G-quadruplex structure of an anti-proliferative DNA sequence.
Do NQ; Chung WJ; Truong THA; Heddi B; Phan AT
Nucleic Acids Res; 2017 Jul; 45(12):7487-7493. PubMed ID: 28549181
[TBL] [Abstract][Full Text] [Related]
34. AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation.
Iturriaga-Goyon E; Vivanco-Rojas O; Magaña-Guerrero FS; Buentello-Volante B; Castro-Salas I; Aguayo-Flores JE; Gracia-Mora I; Rivera-Huerta M; Sánchez-Bartés F; Garfias Y
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884955
[TBL] [Abstract][Full Text] [Related]
35. Magnetic Separation-Assistant Fluorescence Resonance Energy Transfer Inhibition for Highly Sensitive Probing of Nucleolin.
Li YR; Liu Q; Hong Z; Wang HF
Anal Chem; 2015 Dec; 87(24):12183-9. PubMed ID: 26558409
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic applications of AS1411 aptamer, an update review.
Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
[TBL] [Abstract][Full Text] [Related]
37. NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
Del Valle AC; Su CK; Sun YC; Huang YF
Biomater Sci; 2020 Mar; 8(7):1934-1950. PubMed ID: 32039412
[TBL] [Abstract][Full Text] [Related]
38. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
39. Delivery, Effect on Cell Viability, and Plasticity of Modified Aptamer Constructs.
Gissberg O; Zaghloul EM; Lundin KE; Nguyen CH; Landras-Guetta C; Wengel J; Zain R; Smith CI
Nucleic Acid Ther; 2016 Jun; 26(3):183-9. PubMed ID: 26859550
[TBL] [Abstract][Full Text] [Related]
40. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]